Electroconvulsive therapy electrode placement for bipolar state-related targeted engagement
- PMID: 31053985
- PMCID: PMC6499851
- DOI: 10.1186/s40345-019-0146-z
Electroconvulsive therapy electrode placement for bipolar state-related targeted engagement
Abstract
Background: Electroconvulsive therapy (ECT) is an effective treatment for all bipolar states. However, ECT remains underutilized, likely stemming from stigma and the risk of neurocognitive impairment. Neuroimaging research has identified state-specific areas of aberrant brain activity that may serve as targets for therapeutic brain stimulation. Electrode placement determines the geometry of the electric field and can be either non-focal (bitemporal) or more focal (right unilateral or bifrontal). Previous research has shown that electrode placement can impact clinical and cognitive outcomes independent of seizure activity. This review critically examines the evidence that focal (unilateral or bifrontal) electrode placements target specific aberrant circuitry in specific bipolar states to optimize clinical outcomes. We hypothesize that optimal target engagement for a bipolar state will be associated with equivalent efficacy relative to bitemporal non-focal stimulation with less neurocognitive impairment.
Methods: We performed a literature search in the PubMed database. Inclusion criteria included prospective, longitudinal investigations during the ECT series with specific electrode placements within a bipolar state from 2000 to 2018.
Results: We identified investigations that met our inclusion criteria with bipolar mania (n = 6), depression (n = 6), mixed (n = 3) and catatonia (n = 1) states. These studies included clinical outcomes and several included cognitive outcomes, which were discussed separately.
Conclusions: While the heterogeneity of the studies makes comparisons difficult, important patterns included the reduced cognitive side effects, faster rate of response, and equivalent efficacy rates of the focal electrode placements (right unilateral and bifrontal) when compared to non-focal (bitemporal) placement. Further avenues for research include more robust cognitive assessments to separate procedure-related and state-related impairment. In addition, future studies could investigate novel electrode configurations with more specific target engagement for different bipolar states.
Keywords: Bipolar disorder; Electroconvulsive therapy; Electrode placement.
Conflict of interest statement
Dr. Tohen was an employee of Lilly (1997 to 2008) and has received honoraria from or consulted for Abbott, AstraZeneca, Alkermes, Allergan, Bristol Myers Squibb, GlaxoSmithKline, Lilly, Johnson & Johnson, Otsuka, Merck, Gedeon Richter Plc, Sunovion, Forest, Roche, Elan, Lundbeck, Teva, Pamlab, Minerva, Neurocrine, Pfizer, Wyeth and Wiley Publishing; his spouse was a full time employee at Lilly (1998–2013).
Figures
Similar articles
-
Multicenter randomized controlled trial of bifrontal, bitemporal, and right unilateral electroconvulsive therapy in major depressive disorder.Psychiatry Clin Neurosci. 2019 Oct;73(10):636-641. doi: 10.1111/pcn.12907. Epub 2019 Jul 23. Psychiatry Clin Neurosci. 2019. PMID: 31260569 Clinical Trial.
-
Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial.Br J Psychiatry. 2010 Mar;196(3):226-34. doi: 10.1192/bjp.bp.109.066183. Br J Psychiatry. 2010. PMID: 20194546 Free PMC article. Clinical Trial.
-
Comparison of bifrontal and bitemporal ECT for major depression.Am J Psychiatry. 2000 Jan;157(1):121-3. doi: 10.1176/ajp.157.1.121. Am J Psychiatry. 2000. PMID: 10618025 Clinical Trial.
-
Electrode placement in electroconvulsive therapy (ECT): A review of the literature.J ECT. 2010 Sep;26(3):175-80. doi: 10.1097/YCT.0b013e3181e48154. J ECT. 2010. PMID: 20562639 Review.
-
Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies.Health Technol Assess. 2005 Mar;9(9):1-156, iii-iv. doi: 10.3310/hta9090. Health Technol Assess. 2005. PMID: 15774232 Review.
Cited by
-
Development of a Psychosocial Intervention to Promote Treatment Adherence in Patients with Bipolar Disorder at Risk of Cardiovascular Disease.J Clin Med. 2021 Dec 15;10(24):5890. doi: 10.3390/jcm10245890. J Clin Med. 2021. PMID: 34945185 Free PMC article.
-
Brain stimulation treatment for bipolar disorder.Bipolar Disord. 2023 Feb;25(1):9-24. doi: 10.1111/bdi.13283. Epub 2022 Dec 21. Bipolar Disord. 2023. PMID: 36515461 Free PMC article. Review.
References
-
- Abbott CC, McClintock SM, Jones TR, Deng ZD, editors. Engaging medial temporal lobes with ECT pulse amplitude to improve clinical outcomes. West Hollywood: American College of Neuropsychopharmacology; 2016.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous